<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.2minutemedicine.com/feed/</title><link>https://www.2minutemedicine.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Fri, 15 Aug 2025 11:05:16 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>#VisualAbstract: Riociguat Improves Exercise Following Balloon Pulmonary Angioplasty in Patients with Pulmonary Hypertension</title><link>https://www.2minutemedicine.com/visualabstract-riociguat-improves-exercise-following-balloon-pulmonary-angioplasty-in-patients-with-pulmonary-hypertension/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2025/08/2MM_07.27.25_Astrid_2_PHTN-1-300x300.jpg</image_url><description>Click here to read this study in the Lancet. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written c...</description><pubDate>Fri, 15 Aug 2025 15:00:44 GMT</pubDate></item><item><title>FDA Approves First-Ever Treatment for Non-Cystic Fibrosis Bronchiectasis</title><link>https://www.2minutemedicine.com/fda-approves-first-ever-treatment-for-non-cystic-fibrosis-bronchiectasis/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2014/12/50_mg_Tramadol_HCl_tablets_generic_Ultram_marketed_by_Amneal_Pharmaceuticals_rotated-300x150.jpg</image_url><description>Key Points: 1. First FDA-approved therapy for non-cystic fibrosis bronchiectasis; addresses a major unmet respiratory need. 2. Phase 3 data showed sig...</description><pubDate>Fri, 15 Aug 2025 14:15:51 GMT</pubDate></item><item><title>Hydroxychloroquine may have a treatment role for chronic inflammatory cardiomyopathy</title><link>https://www.2minutemedicine.com/hydroxychloroquine-may-have-a-treatment-role-for-chronic-inflammatory-cardiomyopathy/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2020/09/CardiologyApp-300x150.jpg</image_url><description>1. Hydroxychloroquine plus prednisolone reduced the 12-month risk of the composite cardiovascular outcome by 72 percent compared with prednisolone alo...</description><pubDate>Fri, 15 Aug 2025 00:00:02 GMT</pubDate></item><item><title>Talazoparib and enzalutamide improve survival in metastatic castration-resistant prostate cancer</title><link>https://www.2minutemedicine.com/talazoparib-and-enzalutamide-improve-survival-in-metastatic-castration-resistant-prostate-cancer/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2015/01/prostatecancer_edited-300x150.jpg</image_url><description>1. Progression-free survival and overall survival were significantly greater in the combination therapy group compared to enzalutamide alone. 2. Anemi...</description><pubDate>Thu, 14 Aug 2025 22:55:09 GMT</pubDate></item><item><title>2 Minute Medicine: Pharma Roundup – Landmark lung approval, billion-dollar obesity drug deal, oncology safety halt, and GSK’s China push [August 14 2025]</title><link>https://www.2minutemedicine.com/2-minute-medicine-pharma-roundup-landmark-lung-approval-billion-dollar-obesity-drug-deal-oncology-safety-halt-and-gsks-china-push-august-14-2025/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-300x200.png</image_url><description>FDA Approves First-Ever Treatment for Non-Cystic Fibrosis Bronchiectasis Late last week, the U.S. Food and Drug Administration approved Insmed’s Brins...</description><pubDate>Thu, 14 Aug 2025 17:44:10 GMT</pubDate></item></channel></rss>